| CLASS | ABXBACT | LP7755-4 | 
| COMPONENT | Spiramycin | LP16414-2 | 
| PROPERTY | Susc | LP6870-2 | 
| TIME_ASPCT | Pt | LP6960-1 | 
| SYSTEM | Isolate | LP7370-2 | 
| SCALE_TYP | Qn | LP7753-9 | 
| METHOD_TYP | MLC | LP6402-4 | 
| parent | Spiramycin | Isolate | Antibiotic susceptibilities | LP380881-5 | 
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| UNITSREQUIRED | Y | |
| STATUS | ACTIVE | 
| LONG_COMMON_NAME | en-US | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) | 
| LONG_COMMON_NAME | en-US | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) | 
| SHORTNAME | en-US | Spiramycin Islt MLC | 
| ConsumerName | en-US | Susceptibility to Spiramycin | 
| SHORTNAME | es-AR | espiramicina:susceptibilidad:punto en el tiempo:cepa clínica:cuantitativo:concentración letal mínima | 
| SHORTNAME | pt-BR | Spiramycin Islt MLC | 
| LONG_COMMON_NAME | de-DE | Spiramycin [Empfindlichkeit] mittels Bestimmung der minimalen letalen Konzentration (MLK) | 
| LONG_COMMON_NAME | nl-NL | Spiramycine [gevoeligheid] in isolaat d.m.v. minimaal dodelijke concentratie | 
| LONG_COMMON_NAME | es-MX | Espiramicina: Aislado : Punto temporal: Susceptibilidad (microorganismos): Cuantitativo: Concentración mínima letal (MLC) | 
LOINC Version: 2.78